Halozyme (HALO) outlook: acquisitions extend IP beyond 2027, royalties are set to top $1B in 2026, and shares look discounted ...

PHILADELPHIA, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical ...

When Mike Burchard went to his doctor two and a half years ago, complaining of persistent body pain and fatigue, he expected ...

Monash University researchers, alongside key partner Halozyme Therapeutics, report findings in support of shifting the way ...

A fear of needles in a medical setting (often called trypanophobia when it’s more severe) is common and can make TRT injections feel intimidating, but understanding why it happens can make it easier ...

American men are loading up on testosterone—whether they need it or not.

Young men are being encouraged to undergo testosterone testing and start hormone therapy through Instagram and TikTok content that promotes unproven health claims while downplaying medical risks, a ...

Subcutaneous anifrolumab is superior to placebo in multiple systemic lupus erythematosus disease activity measures at 52 ...

Previously lecanemab was only approved as an SC injection for maintenance dosing, following an initial 18 month IV phase.

Accessing Testosterone Replacement Therapy shouldn’t make you want to pull your hair out (especially if that’s one of the ...